Mikhail V. Monakhov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mikhail V. Monakhov has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Aleksey I. Khripun
Pirogov Russian National Research Medical University
2 shared publications - T. P. Chelyapina
Pirogov Russian National Research Medical University
2 shared publications - Александр Николаевич Алимов
Pirogov Russian National Research Medical University
2 shared publications - Станислав Юрьевич Орлов
Pirogov Russian National Research Medical University
2 shared publications - A.M. Olenichev
Buyanov Clinical Hospital
1 shared publication - E.E. Kudryavitskii
Buyanov Clinical Hospital
1 shared publication
Latest Publications
- Open Access
Self-timed movement initiation requires rapid sequential coordination of circuits in prefrontal cortex and cerebellum
The neural ‘chain of events’ necessary for movement initiation is poorly understood, particularly for endogenous actions that are self-timed. Here, we introduce a new task that requires mice to self-initiate a movement with high temporal precision in the absence of external ‘go’ signals. Brief, precisely timed flashes of optogenetic photoinhibition reveal that movement initiation is causally driven by rapid sequential recruitment of neurons in prefrontal cortex and lateral cerebellum.
Open AccessSelf-timed movement initiation requires rapid sequential coordination of circuits in prefrontal cortex and cerebellum
The neural ‘chain of events’ necessary for movement initiation is poorly understood, particularly for endogenous actions that are self-timed. Here, we introduce a new task that requires mice to self-initiate a movement with high temporal precision in the absence of external ‘go’ signals. Brief, precisely timed flashes of optogenetic photoinhibition reveal that movement initiation is causally driven by rapid sequential recruitment of neurons in prefrontal cortex and lateral cerebellum.
- 3 October 2025
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 14 (3)
Endoscopic ultrasonography as an effective tool for predicting complications of biliary pancreatitis
Endoscopic ultrasonography (EUS) is a promising diagnostic method for identifying complications associated with acute biliary pancreatitis (ABP); however, its efficacy and clinical significance require further investigation. Objective. To evaluate the diagnostic effectiveness of EUS in acute biliary pancreatitis. Material and methods. A retrospective analysis included 92 patients with confirmed ABP admitted to V.M. Buyanov City Clinical Hospital (Moscow) between 2017 and 2022. All patients underwent EUS within the first 7 days after symptom onset. Patients were divided into two groups: the main group (n=15) with severe ABP and the control group (n=77) with mild and moderately severe ABP. A comparative analysis of endosonographic signs was performed, followed by ROC analysis to assess the diagnostic accuracy of EUS. Results. Statistically significant predictors of severe ABP included hypoechoic necrotic foci (OR=4.4; 95% CI 1.4—14.3), infiltration of peripancreatic fat (OR=5.7; 95% CI 1.2—27.0), and fluid collections in the retroperitoneal space (OR=14.4; 95% CI 1.8—114.7). The sensitivity of EUS in diagnosing necrotizing pancreatitis was 83.8%, specificity was 60%, and accuracy was 71.9%. Diagnostic efficacy of EUS was statistically comparable to computed tomography (p>0.05). Conclusion. EUS is an effective and safe diagnostic modality for ABP, comparable in informativeness to CT, and can be utilized for early detection of severe disease forms and optimization of therapeutic strategies.
- 3 October 2025
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 14 (3)
Endoscopic ultrasonography as an effective tool for predicting complications of biliary pancreatitis
Endoscopic ultrasonography (EUS) is a promising diagnostic method for identifying complications associated with acute biliary pancreatitis (ABP); however, its efficacy and clinical significance require further investigation. Objective. To evaluate the diagnostic effectiveness of EUS in acute biliary pancreatitis. Material and methods. A retrospective analysis included 92 patients with confirmed ABP admitted to V.M. Buyanov City Clinical Hospital (Moscow) between 2017 and 2022. All patients underwent EUS within the first 7 days after symptom onset. Patients were divided into two groups: the main group (n=15) with severe ABP and the control group (n=77) with mild and moderately severe ABP. A comparative analysis of endosonographic signs was performed, followed by ROC analysis to assess the diagnostic accuracy of EUS. Results. Statistically significant predictors of severe ABP included hypoechoic necrotic foci (OR=4.4; 95% CI 1.4—14.3), infiltration of peripancreatic fat (OR=5.7; 95% CI 1.2—27.0), and fluid collections in the retroperitoneal space (OR=14.4; 95% CI 1.8—114.7). The sensitivity of EUS in diagnosing necrotizing pancreatitis was 83.8%, specificity was 60%, and accuracy was 71.9%. Diagnostic efficacy of EUS was statistically comparable to computed tomography (p>0.05). Conclusion. EUS is an effective and safe diagnostic modality for ABP, comparable in informativeness to CT, and can be utilized for early detection of severe disease forms and optimization of therapeutic strategies.
- 11 August 2025
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 8,p. 23-29
Efficacy and safety of pancreatic stenting in acute biliary pancreatitis
Objective. To evaluate the efficacy and safety of early pancreatic stenting in patients with acute biliary pancreatitis. Material and methods. We retrospectively analyzed the effect of early (within 48 hours after admission) pancreatic stenting on severity of disease, incidence of complications, mortality and hospital-stay in patients with severe acute biliary pancreatitis. Moreover, there were patients with acute biliary pancreatitis who underwent delayed endoscopic retrograde intervention and only conservative therapy. Results. Early pancreatic stenting reduced the risk of local (p=0.047) and systemic complications (p=0.027) compared to delayed intervention and conservative treatment. Early pancreatic stenting contributed to shorter hospital-stay when compared with delayed intervention (p=0.038). There was no between-group difference in mortality or severity of disease. Pancreatic stenting after 48 hours had no advantages over early stenting or conservative treatment, but significantly increased the risk of infected pancreatic necrosis (p=0.023). Conclusion. Early pancreatic stenting seems to be safe and effective procedure in reducing the number of complications in patients with acute biliary pancreatitis. Neither early nor late pancreatic stenting has a significant effect on disease severity, mortality and hospital-stay.
- 11 August 2025
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 8,p. 23-29
Efficacy and safety of pancreatic stenting in acute biliary pancreatitis
Objective. To evaluate the efficacy and safety of early pancreatic stenting in patients with acute biliary pancreatitis. Material and methods. We retrospectively analyzed the effect of early (within 48 hours after admission) pancreatic stenting on severity of disease, incidence of complications, mortality and hospital-stay in patients with severe acute biliary pancreatitis. Moreover, there were patients with acute biliary pancreatitis who underwent delayed endoscopic retrograde intervention and only conservative therapy. Results. Early pancreatic stenting reduced the risk of local (p=0.047) and systemic complications (p=0.027) compared to delayed intervention and conservative treatment. Early pancreatic stenting contributed to shorter hospital-stay when compared with delayed intervention (p=0.038). There was no between-group difference in mortality or severity of disease. Pancreatic stenting after 48 hours had no advantages over early stenting or conservative treatment, but significantly increased the risk of infected pancreatic necrosis (p=0.023). Conclusion. Early pancreatic stenting seems to be safe and effective procedure in reducing the number of complications in patients with acute biliary pancreatitis. Neither early nor late pancreatic stenting has a significant effect on disease severity, mortality and hospital-stay.